IDEAYA Biosciences, Inc. Reports Fourth Quarter 2020 Financial Results and Provides Business Update

Go back to IDEAYA Biosciences, Inc. Reports Fourth Quarter 2020 Financial Results and Provides Business Update

IDEAYA Biosciences (IDYA) Reports Q4 Loss of $0.18/sh

March 23, 2021 6:28 AM EDT

IDEAYA Biosciences (NASDAQ: IDYA) reported Q4 EPS of ($0.18), versus ($0.53) reported last year. Revenue for the quarter came in at $10.57 million, versus $0 reported last year.

For earnings history and earnings-related data on IDEAYA Biosciences (IDYA) click here.

... More